Literature DB >> 29736630

Variations in clinical management of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation according to different equations for estimating renal function : Post hoc analysis of a prospective cohort.

Vincenzo Livio Malavasi1, Daniele Pettorelli1, Elisa Fantecchi1, Cristina Zoccali1, Giuliana Laronga1, Tommaso Trenti2, Gregory Yoke Hong Lip3, Giuseppe Boriani4.   

Abstract

Prescription of non-vitamin K antagonist oral anticoagulants (NOACs) requires an assessment of renal function (RF) and the Cockcroft-Gault (CG) equation is traditionally recommended. The objective of the study was to evaluate the potential changes in NOACs management using different equations for estimating RF. In a post hoc analysis of a prospective cohort of patients with atrial fibrillation, we considered different equations: (1) CG for creatinine clearance (CrCl), (2) modification of diet in renal disease (MDRD), (3) CKD-EPI, (4) Berlin Initiative Study 1 (BIS-1) and (5) full age spectrum (FAS), for glomerular filtration rate (GFR). RF was classified according to CrCl in three categories: severely depressed (SD-RF) < 30 ml/min; moderately depressed (MD-RF) 30-49 ml/min; preserved/mildly depressed (P-RF) ≥ 50 ml/min. Concordances in the assignments were analyzed. A population of 402 patients (61.2% males, age 72 ± 11) was categorized according to CrCl: 12 patients (2.9%) as SD-RF, 81 (20.1%) as MD-RF, 309 (76.8%) as P-RF. A potential change in NOACs management could occur using GFR equations rather than CrCl in 16.9% of patients using MDRD formula, in 11.7% using BIS-1, in 14.7% using CKD-EPI and in 12.9% using the FAS equation. Important changes in RF estimates were more frequent in patients aged ≥ 75, but also BMI had a meaningful impact. Use of equations estimating GFR instead of the Cockcroft-Gault equation may result in changes in NOACs management in 12-17% of patients. In the elderly ≥ 75, more pronounced changes in RF classification are detectable according to different equations and NOACs dosing should be further investigated.

Entities:  

Keywords:  Anticoagulation; Atrial fibrillation; Creatinine clearance; Glomerular filtration rate; Non-vitamin K antagonists oral anticoagulants; Renal function

Mesh:

Substances:

Year:  2018        PMID: 29736630     DOI: 10.1007/s11739-018-1857-3

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


  34 in total

1.  Understanding interobserver agreement: the kappa statistic.

Authors:  Anthony J Viera; Joanne M Garrett
Journal:  Fam Med       Date:  2005-05       Impact factor: 1.756

2.  Assessing kidney function--measured and estimated glomerular filtration rate.

Authors:  Lesley A Stevens; Josef Coresh; Tom Greene; Andrew S Levey
Journal:  N Engl J Med       Date:  2006-06-08       Impact factor: 91.245

Review 3.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.

Authors:  Craig T January; L Samuel Wann; Joseph S Alpert; Hugh Calkins; Joaquin E Cigarroa; Joseph C Cleveland; Jamie B Conti; Patrick T Ellinor; Michael D Ezekowitz; Michael E Field; Katherine T Murray; Ralph L Sacco; William G Stevenson; Patrick J Tchou; Cynthia M Tracy; Clyde W Yancy
Journal:  J Am Coll Cardiol       Date:  2014-03-28       Impact factor: 24.094

4.  Comparison of estimated glomerular filtration rate equations for dosing new oral anticoagulants in patients with atrial fibrillation.

Authors:  Sergio Manzano-Fernández; José M Andreu-Cayuelas; Francisco Marín; Esteban Orenes-Piñero; Pilar Gallego; Mariano Valdés; Vicente Vicente; Gregory Y H Lip; Vanessa Roldán
Journal:  Rev Esp Cardiol (Engl Ed)       Date:  2014-11-20

Review 5.  Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE).

Authors:  Gregory Y H Lip; Jean Philippe Collet; Raffaele de Caterina; Laurent Fauchier; Deirdre A Lane; Torben B Larsen; Francisco Marin; Joao Morais; Calambur Narasimhan; Brian Olshansky; Luc Pierard; Tatjana Potpara; Nizal Sarrafzadegan; Karen Sliwa; Gonzalo Varela; Gemma Vilahur; Thomas Weiss; Giuseppe Boriani; Bianca Rocca
Journal:  Europace       Date:  2017-11-01       Impact factor: 5.214

6.  A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group.

Authors:  A S Levey; J P Bosch; J B Lewis; T Greene; N Rogers; D Roth
Journal:  Ann Intern Med       Date:  1999-03-16       Impact factor: 25.391

7.  Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation.

Authors:  Robert G Hart; Lesly A Pearce; Maria I Aguilar
Journal:  Ann Intern Med       Date:  2007-06-19       Impact factor: 25.391

8.  Comparison of drug dosing recommendations based on measured GFR and kidney function estimating equations.

Authors:  Lesley A Stevens; Thomas D Nolin; Michelle M Richardson; Harold I Feldman; Julia B Lewis; Roger Rodby; Raymond Townsend; Aghogho Okparavero; Yaping Lucy Zhang; Christopher H Schmid; Andrew S Levey
Journal:  Am J Kidney Dis       Date:  2009-05-17       Impact factor: 8.860

9.  Edoxaban versus warfarin in patients with atrial fibrillation.

Authors:  Robert P Giugliano; Christian T Ruff; Eugene Braunwald; Sabina A Murphy; Stephen D Wiviott; Jonathan L Halperin; Albert L Waldo; Michael D Ezekowitz; Jeffrey I Weitz; Jindřich Špinar; Witold Ruzyllo; Mikhail Ruda; Yukihiro Koretsune; Joshua Betcher; Minggao Shi; Laura T Grip; Shirali P Patel; Indravadan Patel; James J Hanyok; Michele Mercuri; Elliott M Antman
Journal:  N Engl J Med       Date:  2013-11-19       Impact factor: 91.245

10.  Risk profiles and antithrombotic treatment of patients newly diagnosed with atrial fibrillation at risk of stroke: perspectives from the international, observational, prospective GARFIELD registry.

Authors:  Ajay K Kakkar; Iris Mueller; Jean-Pierre Bassand; David A Fitzmaurice; Samuel Z Goldhaber; Shinya Goto; Sylvia Haas; Werner Hacke; Gregory Y H Lip; Lorenzo G Mantovani; Alexander G G Turpie; Martin van Eickels; Frank Misselwitz; Sophie Rushton-Smith; Gloria Kayani; Peter Wilkinson; Freek W A Verheugt
Journal:  PLoS One       Date:  2013-05-21       Impact factor: 3.240

View more
  8 in total

1.  Female sex and stroke in atrial fibrillation: an intriguing relationship.

Authors:  Giuseppe Boriani; Jacopo Colella; Jacopo Imberti; Elisa Fantecchi; Marco Vitolo
Journal:  Intern Emerg Med       Date:  2019-08-08       Impact factor: 3.397

2.  Estimating renal function in patients with atrial fibrillation: which dose of direct oral anticoagulants?

Authors:  Nicoletta Riva; Walter Ageno; Alex Gatt
Journal:  Intern Emerg Med       Date:  2018-05-24       Impact factor: 3.397

3.  A focus on direct oral anticoagulants: "old" and possible new indications and efforts for a better clinical management.

Authors:  Domenico Prisco
Journal:  Intern Emerg Med       Date:  2018-09-21       Impact factor: 3.397

4.  Treatment implications of renal disease in patients with atrial fibrillation: The BALKAN-AF survey.

Authors:  Monika Kozieł; Stefan Simovic; Nikola Pavlovic; Milan Nedeljkovic; Aleksandar Kocijancic; Vilma Paparisto; Ljilja Music; Elina Trendafilova; Anca Rodica Dan; Sime Manola; Zumreta Kusljugic; Gheorghe-Andrei Dan; Gregory Y H Lip; Tatjana S Potpara
Journal:  J Arrhythm       Date:  2020-07-19

5.  Chronic Kidney Disease with Mild and Mild to Moderate Reduction in Renal Function and Long-Term Recurrences of Atrial Fibrillation after Pulmonary Vein Cryoballoon Ablation.

Authors:  Giuseppe Boriani; Saverio Iacopino; Giuseppe Arena; Paolo Pieragnoli; Roberto Verlato; Massimiliano Manfrin; Giulio Molon; Giovanni Rovaris; Antonio Curnis; Giovanni Battista Perego; Antonio Dello Russo; Maurizio Landolina; Marco Vitolo; Claudio Tondo
Journal:  J Cardiovasc Dev Dis       Date:  2022-04-21

6.  Kidney Function According to Different Equations in Patients Admitted to a Cardiology Unit and Impact on Outcome.

Authors:  Vincenzo Livio Malavasi; Anna Chiara Valenti; Sara Ruggerini; Marcella Manicardi; Carlotta Orlandi; Daria Sgreccia; Marco Vitolo; Marco Proietti; Gregory Y H Lip; Giuseppe Boriani
Journal:  J Clin Med       Date:  2022-02-08       Impact factor: 4.241

7.  Different glomerular filtration rate estimating formula for prescribing DOACs in oldest patients: appropriate dosage and bleeding risk. Post hoc analysis of a prospective cohort.

Authors:  Valeria Calsolaro; Chukwuma Okoye; Sara Rogani; Alessia Maria Calabrese; Umberto Dell'Agnello; Rachele Antognoli; Daniela Guarino; Fabio Monzani
Journal:  Aging Clin Exp Res       Date:  2021-10-18       Impact factor: 3.636

8.  Appropriateness of Non-vitamin K Antagonist Oral Anticoagulants Dosing According to Different Prescription Guides Used in Belgian Ambulatory Care.

Authors:  Michiel Delesie; Arne Ballet; Cedric Hillegeer; Lien Desteghe; Paul Dendale; Hein Heidbuchel
Journal:  Clin Drug Investig       Date:  2022-08-20       Impact factor: 3.580

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.